Deutsche Bank Ag\ Avid Bioservices, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 58,086 shares of CDMO stock, worth $725,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,086

Previous 37,837 53.52%

Holding current value

$725,494

Previous $430,000 66.74%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$9.96 - $12.36 $201,680 - $250,277	20,249 Added 53.52%	58,086 $717,000
Q3 2024 Nov 13, 2024	BUY	$6.7 - $12.45 $32,662 - $60,693	4,875 Added 14.79%	37,837 $430,000
Q2 2024 Aug 14, 2024	SELL	$6.34 - $9.28 $5,148 - $7,535	-812 Reduced 2.4%	32,962 $235,000
Q1 2024 May 15, 2024	SELL	$5.86 - $8.79 $380,161 - $570,242	-64,874 Reduced 65.76%	33,774 $226,000
Q4 2023 Feb 14, 2024	BUY	$4.64 - $9.56 $300,662 - $619,468	64,798 Added 191.43%	98,648 $641,000
Q3 2023 Nov 09, 2023	BUY	$9.4 - $14.04 $36,199 - $54,068	3,851 Added 12.84%	33,850 $319,000
Q2 2023 Aug 14, 2023	SELL	$12.96 - $20.93 $1.07 Million - $1.72 Million	-82,417 Reduced 73.31%	29,999 $419,000
Q1 2023 May 15, 2023	BUY	$13.48 - $18.79 $1.07 Million - $1.49 Million	79,184 Added 238.28%	112,416 $2.11 Million
Q4 2022 Feb 13, 2023	BUY	$12.61 - $18.74 $53,932 - $80,150	4,277 Added 14.77%	33,232 $457,000
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $99,568 - $132,238	-6,495 Reduced 18.32%	28,955 $553,000
Q2 2022 Aug 11, 2022	SELL	$11.63 - $21.55 $24,667 - $45,707	-2,121 Reduced 5.65%	35,450 $541,000
Q1 2022 May 13, 2022	SELL	$16.63 - $27.73 $62,611 - $104,403	-3,765 Reduced 9.11%	37,571 $765,000
Q4 2021 Feb 11, 2022	BUY	$20.7 - $34.18 $34,879 - $57,593	1,685 Added 4.25%	41,336 $1.21 Million
Q3 2021 Nov 04, 2021	SELL	$19.05 - $28.32 $396,297 - $589,140	-20,803 Reduced 34.41%	39,651 $855,000
Q2 2021 Aug 11, 2021	BUY	$18.93 - $25.65 $21,655 - $29,343	1,144 Added 1.93%	60,454 $1.55 Million
Q1 2021 May 13, 2021	BUY	$11.86 - $21.77 $86,411 - $158,616	7,286 Added 14.01%	59,310 $1.08 Million
Q4 2020 Feb 16, 2021	BUY	$7.25 - $11.76 $117,268 - $190,218	16,175 Added 45.12%	52,024 $600,000
Q3 2020 Nov 12, 2020	BUY	$6.53 - $8.6 $51,129 - $67,338	7,830 Added 27.95%	35,849 $274,000
Q2 2020 Aug 13, 2020	BUY	$4.11 - $6.78 $5,322 - $8,780	1,295 Added 4.85%	28,019 $183,000
Q1 2020 May 14, 2020	SELL	$3.15 - $7.39 $117,047 - $274,597	-37,158 Reduced 58.17%	26,724 $137,000
Q4 2019 Feb 14, 2020	BUY	$5.01 - $8.16 $237,804 - $387,322	47,466 Added 289.14%	63,882 $489,000
Q3 2019 Nov 14, 2019	SELL	$5.07 - $7.08 $138,476 - $193,376	-27,313 Reduced 62.46%	16,416 $86,000
Q2 2019 Aug 14, 2019	SELL	$3.43 - $5.6 $163,103 - $266,291	-47,552 Reduced 52.09%	43,729 $243,000
Q1 2019 May 15, 2019	SELL	$3.56 - $4.82 $297,487 - $402,778	-83,564 Reduced 47.79%	91,281 $387,000
Q4 2018 Feb 14, 2019	BUY	$4.04 - $6.75 $238,828 - $399,033	59,116 Added 51.08%	174,845 $716,000
Q3 2018 Dec 21, 2021	BUY	$4.28 - $7.32 $57,086 - $97,634	13,338 Added 13.03%	115,729 $795,000
Q3 2018 Nov 14, 2018	BUY	$4.28 - $7.32 $22,106 - $37,807	5,165 Added 5.31%	102,391 $701,000
Q2 2018 Apr 21, 2020	BUY	$3.1 - $3.93 $50,951 - $64,593	16,436 Added 20.34%	97,226 $381,000
Q2 2018 Aug 14, 2018	BUY	$3.1 - $3.93 $203,465 - $257,941	65,634 Added 433.06%	80,790 $315,000
Q1 2018 Oct 18, 2019	SELL	$2.32 - $4.22 $30 - $54	-13 Reduced 0.09%	15,156 $44,000
Q1 2018 May 15, 2018	BUY	$2.32 - $4.22 $35,192 - $64,013	15,169 New	15,169 $44,000

Others Institutions Holding CDMO

# of Institutions

214

Shares Held

78.6M

Call Options Held

239K

Put Options Held

108K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account